A study of artemisinin combination therapy given at delivery to prevent postpartum malaria and to young infants to treat uncomplicated malaria

Status	Finished
Effective start/end date	1/01/17 → 30/06/21

Access Project

Artemisinin combination therapy at delivery to prevent postpartum malaria: A randomised open-label controlled trial
Tesine, P., Woon, S. A., Laman, M., Yadi, G., Yambo, P., Kasian, B., Lorry, L., Robinson, L. J., Salman, S., Batty, K. T., Pomat, W., Manning, L., Davis, W. A., Davis, T. M. E. & Moore, B. R., Dec 2024, In: International Journal of Infectious Diseases. 149, 8 p., 107258.
Research output: Contribution to journal › Article › peer-review

Open Access
Pharmacokinetic properties of the antimalarial combination therapy artemether–lumefantrine in normal-weight, overweight and obese healthy male adults
Sugiarto, S. R., Page-Sharp, M., Drinkwater, J. J., Davis, W. A., Salman, S. & Davis, T. M. E., Jan 2022, In: International Journal of Antimicrobial Agents. 59, 1, 106482.
Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)
The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children
Sugiarto, S. R., Bwire, G. M., Moore, B. R., Page-Sharp, M., Manning, L., Batty, K. T., Minzi, O. M. S., Ngasala, B., Davis, T. M. E., Makani, J. & Salman, S., Aug 2022, In: International Journal for Parasitology: Drugs and Drug Resistance. 19, p. 31-39 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access